Nabil Adra, MD | IU Health

Dr. Nabil Adra, MD

Claim this profile

Indiana University Melvin and Bren Simon Cancer Center

Studies Prostate Cancer
Studies Thyroid Cancer
14 reported clinical trials
28 drugs studied

Affiliated Hospitals

Image of trial facility.
Indiana University/Melvin And Bren Simon Cancer Center
Image of trial facility.
Indiana University Melvin And Bren Simon Comprehensive Cancer Center

Clinical Trials Nabil Adra, MD is currently running

Image of trial facility.

Immunotherapy + Chemotherapy

for Bladder Cancer

Upon successful screening and registration, enrollment to durvalumab monotherapy (cohort 1) will begin. If DLT criteria outlined in the protocol are exceeded with durvalumab monotherapy (cohort 1), the study will close. Provided the safety of durvalumab monotherapy is established, enrollment to combination regimen cohorts will proceed. Cohorts will simultaneously enroll in parallel to each other with patients assigned to cohorts based on patient slot availability and study site choice of radiation arm participation. Patient assignment to future phase 1 arms would proceed similarly. Within BCG-containing cohorts, treatment will begin at full-dose BCG. If DLT criteria outlined in Section 5.1.4 are exceeded with full-dose BCG, a one level dose reduction of BCG will be implemented. If DLT criteria outlined in Section 5.1.4 are exceeded with reduced-dose BCG, the BCG-containing cohort will not proceed to Phase 2 of the study. Similarly, if DLT criteria outlined in Section 5.1.4 are exceeded within non-BCG containing cohorts, the non-BCG containing cohort will not proceed to phase 2 of the study. Due to the prolonged half-life of antibody therapies, no dose adjustments are planned for durvalumab in any of the cohorts.
Recruiting1 award Phase 1 & 26 criteria
Image of trial facility.

Radium-223 + Docetaxel

for Prostate Cancer

The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. Earlier studies helped show that the combination is safe, but the combination has not been proven to work better than either drug alone. The goal of this study is to find out if combining docetaxel and radium-223 is better than giving either drug by itself.
Recruiting2 awards Phase 323 criteria

More about Nabil Adra, MD

Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Nabil Adra, MD has experience with
  • Nivolumab
  • Cabozantinib
  • Docetaxel
  • Etoposide
  • ARX517
  • 177Lu-J591

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nabil Adra, MD specialize in?
Nabil Adra, MD focuses on Prostate Cancer and Thyroid Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Nabil Adra, MD currently recruiting for clinical trials?
Yes, Nabil Adra, MD is currently recruiting for 5 clinical trials in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Nabil Adra, MD has studied deeply?
Yes, Nabil Adra, MD has studied treatments such as Nivolumab, Cabozantinib, Docetaxel.
What is the best way to schedule an appointment with Nabil Adra, MD?
Apply for one of the trials that Nabil Adra, MD is conducting.
What is the office address of Nabil Adra, MD?
The office of Nabil Adra, MD is located at: Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana 46202 United States. This is the address for their practice at the Indiana University Melvin and Bren Simon Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security